DOI 10.1016/j.jpurol.2026.105879
Being born small for gestational age is an independent risk factor for failure of endoscopic treatment in vesicoureteral reflux.
Аннотация
BACKGROUND
Endoscopic treatment has become a widely used minimally invasive alternative to ureteral reimplantation for vesicoureteral reflux (VUR) in children, with reported success rates between 70% and 90%. Despite advances in technique and patient selection, a reliable predictive model for treatment outcomes is still lacking. Small-for-gestational-age (SGA) status, reflecting perinatal growth restriction, has been linked to congenital urological disorders and developmental disparities, but its impact on VUR treatment outcomes remains unknown.
OBJECTIVE
To investigate whether being born SGA is associated with an increased risk of endoscopic treatment failure in children with primary VUR.
STUDY
DESIGN
This retrospective cohort study included children who underwent endoscopic treatment for primary VUR between 2013 and 2023 at a tertiary teaching hospital. Clinical variables included birth parameters, reflux grade, renal scarring, differential renal function (DRF), voiding dysfunction, and operative details. SGA was defined as birth weight below the 10th percentile for gestational age and sex. Univariate and multivariate logistic regression analyses were performed to identify predictors of treatment failure.
RESULTS
Sixty-five children (40 girls, 25 boys; 104 ureters) were included. Ten patients (15.4%) were SGA and 55 (84.6%) non-SGA. There were no significant differences between the SGA and non-SGA groups in gestational age at birth, VUR grade distribution, renal scarring, DRF, age at operation or injection material (all p > 0.05). The success rate was significantly lower in SGA patients compared with non-SGA peers (27.8% vs. 79.1%, p < 0.001). Multivariate analysis identified SGA as an independent risk factor for treatment failure (OR: 12.76 (95% CI: 3.49-46.61, p = 0.001).
CONCLUSION
Being born SGA is associated with a markedly reduced success rate of endoscopic treatment for primary VUR, independent of other prognostic factors. Recognition of SGA status may improve preoperative risk assessment and guide surgical decision-making. Further validation in larger cohorts could support its integration into clinical counseling and individualized treatment planning.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.